About Observe Medical

Observe Medical is a Nordic medtech company that develops, markets and sells innovative medtech products for the global market. The company is committed to improving patient welfare and outcomes, increase clinical data accuracy and promoting positive health economics.

The company seeks to drive growth by leveraging its expertise in sales and commercialisation and has a broad portfolio of medtech products, mainly across urine measurement, ultrasound, anaesthesiology/ICUs, surgery and wound care.

Observe Medical is headquartered in Oslo, Norway, with wholly-owned subsidiaries in Narvik, Norway, Gothenburg, Sweden, Oulu, Finland and Seattle in the US. In addition, Observe Medical operates an international distributor and partner network.

Management team

jørgen


Jørgen Mann

INTERIM CHIEF EXECUTIVE OFFICER

Appointed Interim CEO from February 2024. With nearly 20 years of experience in sales and senior management roles from global medtech companies in Europe, he brings highly relevant experience to Observe Medical, as the company strengthens its commercial efforts in the market.

Johan

JOHAN M. FAGERLI

INTERIM CHIEF FINANCIAL OFFICER

20 years-experience from various roles within financial management, business controlling and accounting across multiple industries such as real estate, road construction and telecom. Joined Observe Medical in 2021 

rune

RUNE NYSTAD

CHIEF DEVELOPMENT OFFICER

Prior to Observe Medical, Rune was the CEO of Biim Ultrasound. He has over 20 years of experience in global medtech and industrial technology from the Nordics, US, Germany, Ireland and Hong Kong, including Boston Scientific. Has previously been involved in multiple successful start-ups and over 30 product launches.

Board of directors

TERJE BAKKEN

CHAIRMAN OF THE BOARD

Terje is a partner in the Norwegian investment firm Reiten & Co and has extensive experience as chairman in public listed and private companies, including Navamedic ASA. Organized the spin-off of Observe Medical from Navamedic in 2019

KATHRINE GAMBORG ANDREASSEN

BOARD MEMBER

Chief Executive Officer of Navamedic since 2018. Comprehensive experience from marketing and executive positions within consumer health, i.a. from Novicus Pharma, Weifa and Orkla.

SANNA RYDBERG

BOARD MEMBER

Currently CEO at Unilabs Sweden AB, and with approximately 25 years of experience from leading positions in life science industry, most recently as CEO of Arcoma AB and earlier as CEO in Eurofins BioPharma Product Testing Sweden AB and Head of Healthcare for  Northern Europe at Linde. 

LINE TØNNESSEN

BOARD MEMBER

Line Tønnessen, a Norwegian citizen, holds the position as Investment Director in Reiten & Co. Tønnessen currently sits on the Board of Directors of Vow Green Metals AS and holds a Bachelor of Business Administration from the BI Norwegian Business School, an MBA in Finance from the Norwegian School of Economics (NHH), and is a Certified Financial Analyst (CFA).

ESKILD ENDRERUD

BOARD MEMBER

Eskild Endrerud, a Norwegian citizen, holds the position as CEO and Chairman of the Board of Seed Capital AS, a family-owned investment company. Endrerud has previously been Chairman of the Board and CFO of Biim Ultrasound AS which now is a part of Observe Medical ASA. Endrerud holds a BSc in Entrepreneurship and Business from BI Norwegian Business School, as well as a Master in Real Estate Development from NMBU Norwegian Business School.